Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] LIG D&A (079550) – Eugene Investment & Securities | Global Demand Spillover · CapEx Expansion · Long-term Compounding / 2026-08-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-term Exclusive Contracts · 2029 Target EPS · Structural ASP Hikes / 2026-06-01 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Platform Valuation · Pipeline Milestones · Deal Expansion / 2025-08-12 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Cash Flow · Shareholder Returns / 2026-01-30 Research
  • [Research] LIG D&A (079550/KS) – SK Securities | 1Q26 Earnings Beat · Overdone Correction · Global Demand Expansion / 2026-05-08 Research
  • [Research] Hanwha Ocean (042660) – Kiwoom | Merchant Profit Driver · High-Price Mix Scale-Up · Naval & Offshore Orders / 2026-04-29 Shipbuilding
  • [Research] ABL Bio (298380) – Kyobo Securities | ABL001 Clinical Data · Market Overreaction · Grabody-B Potential / 2026-04-29 Research

[Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23

Posted on March 23, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Mirae Asset Securities

Analyst : Younggun Kim

Investment Rating : BUY (Maintained)

Target Price : 1,540,000 KRW (Maintained)

Core Momentum : Resilient memory pricing and structural capacity constraints are driving upward earnings revisions, while the planned U.S. ADR listing provides a potential catalyst for multiple expansion and valuation re-rating.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price / Investment Rating: 1,540,000 KRW / BUY (Maintain)
  • Current Price (as of 26/3/20): 1,007,000 KRW (Upside potential: 52.9%)
  • Market Capitalization: 717,691 billion KRW (KOSPI 5,781.20pt)
  • Key Financial Metrics (2024 / 2025 / 2026F / 2027F / 2028F):
    • Revenue: 66,193 billion KRW / 97,147 billion KRW / 312,741 billion KRW / 426,484 billion KRW / 483,824 billion KRW
    • Operating Profit: 23,467 billion KRW / 47,206 billion KRW / 230,464 billion KRW / 317,882 billion KRW / 358,828 billion KRW
    • Net Income: 19,789 billion KRW / 42,919 billion KRW / 195,971 billion KRW / 279,987 billion KRW / 329,244 billion KRW
    • EPS: 27,182 KRW / 58,955 KRW / 274,331 KRW / 392,853 KRW / 461,965 KRW
    • P/E: 6.4x / 11.0x / 3.7x / 2.6x / 2.2x
    • P/B: 1.7x / 3.9x / 2.3x / 1.2x / 0.8x
    • ROE: 31.1% / 44.2% / 90.1% / 61.8% / 43.6%

🚀 2. [Market Opportunities & Business Outlook]

  • Upward Revisions to Earnings Forecasts: Reflecting favorable memory pricing dynamics, 1Q26 estimates have been lifted by 10.9% for revenue and 13.9% for operating profit, reaching 52.5 trillion KRW and 36.7 trillion KRW (+91.6% QoQ), respectively. Full-year 2026 projections have also been revised upward by 11.0% and 12.8% to 313 trillion KRW in revenue (+222% YoY) and 230.5 trillion KRW in operating profit (+388% YoY).
  • Memory Pricing and Sustainability: Despite lingering peak-out concerns, elevated price levels and robust return profiles are expected to persist, driven by 1) irreversible mobile specification enhancements, 2) pent-up demand resulting from supply-demand bifurcations between data centers and consumer IT, and 3) structural bottlenecks in capacity additions. As of mid-March, 4Q26 contract prices for PC DRAM DDR5 remained flat while DDR4 rose 2.9%, leaving room for potential upward revisions to the 4Q26 ASP/Gb projection ($1.6).
  • ADR Issuance Momentum: Media reports have highlighted management’s intent to pursue a U.S. American Depositary Receipt (ADR) listing. Beyond multiple expansion stemming from exposure to a premium capital market, potential share price momentum could be significantly amplified if the issuance is accompanied by substantial treasury share buybacks.
  • Valuation Attractiveness: The 12-month forward P/E trades at an exceptionally low 2.9x, while the P/B sits near historical averages at 1.7x—presenting very limited valuation burden relative to the vastly elevated ROE framework.

📝 Editor’s Comment (Perspective)

The analyst evaluates that solid pricing momentum and supply tightness have propelled meaningful upward revisions to both quarterly and annual earnings outlooks. Furthermore, the analysis highlights that pursuing a U.S. ADR listing will serve as a pivotal catalyst to drive multiple re-rating through access to a premium valuation market alongside potential shareholder enhancement initiatives.

To determine whether this investment thesis is unfolding as projected, key items to monitor include the delivery of the 36.7 trillion KRW operating profit for Q1, the trajectory of memory prices and ASPs through the second half, and concrete developments regarding the ADR issuance terms and accompanying treasury share buybacks. These developments can be tracked through upcoming quarterly and annual earnings releases, official corporate IR materials, and regulatory disclosures via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] Samsung SDI (006400) – Mirae Asset Securities | BBU Momentum · Hungarian Utilization Rebound · 2026 Operating Profit Turnaround / 2026-03-18
Next Post: [Research] LigaChem Biosciences (141080) – Shinhan Securities | ConjuALL · Clinical Milestones · Big Pharma L/O / 2026-03-24

Related Posts

  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | MLCC Price Hike · Supply Shortage · Earnings Acceleration / 2026-07-31 Research
  • [Research] LigaChem Biosciences (141080) – Yuanta Securities | Payload Chemistry · Safety Profile · Differentiation / 2025-05-22 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Supply Shortage · Memory ASP · Profitability / 2026-01-30 Research
  • [Research] Samsung SDI (006400) – SK Securities | Plant Utilization Recovery · North America ESS Expansion · AMPC Benefits / 2026-04-29 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Defense Export Expansion · GR Turnaround · 2026E Upward / 2026-02-19 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Earnings Sustainability / 2026-04-24 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI MLCC Shortage · Price Cycle · High-End Margin / 2026-07-31 Research
  • [IR] SK hynix (000660 / SKHY) – Q2 2024 Earnings Presentation / 2024-07-25 IR Room
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2023 Earnings Presentation / 2024-01-31 IR Room
  • [Research] LIG D&A (079550) – Daishin Securities | 2Q26 Review · Backlog Realization · Export Margin Expansion / 2026-08-10 Research
  • [Research] Hanwha Ocean (042660) – Daishin | Merchant Vessel Margin · FX Impact · US Navy Logistics Synergy / 2026-07-29 Research
  • [Research] SK hynix (000660 / SKHY) – Hyundai Motor | Agentic AI · Memory Demand · Cycle Stability / 2026-05-13 Research
  • [Research] ABL Bio (298380) – Kyobo Securities | ABL001 Clinical Data · Market Overreaction · Grabody-B Potential / 2026-04-29 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme